Dongyue Group Valuation

Is 189 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 189 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 189 (HK$6.68) is trading above our estimate of fair value (HK$5.13)

Significantly Below Fair Value: 189 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 189?

Key metric: As 189 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 189. This is calculated by dividing 189's market cap by their current earnings.
What is 189's PE Ratio?
PE Ratio14.7x
EarningsCN¥731.57m
Market CapCN¥10.38b

Price to Earnings Ratio vs Peers

How does 189's PE Ratio compare to its peers?

The above table shows the PE ratio for 189 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26.9x
336 Huabao International Holdings
63.8xn/aHK$7.4b
6616 Global New Material International Holdings
20.3x29.0%HK$4.4b
3318 China Boton Group
13xn/aHK$1.8b
609 Tiande Chemical Holdings
10.3xn/aHK$965.2m
189 Dongyue Group
14.7x42.6%HK$11.2b

Price-To-Earnings vs Peers: 189 is good value based on its Price-To-Earnings Ratio (14.7x) compared to the peer average (26.9x).


Price to Earnings Ratio vs Industry

How does 189's PE Ratio compare vs other companies in the HK Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
189 14.7xIndustry Avg. 9.3xNo. of Companies5PE0816243240+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 189 is expensive based on its Price-To-Earnings Ratio (14.7x) compared to the Hong Kong Chemicals industry average (9.3x).


Price to Earnings Ratio vs Fair Ratio

What is 189's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

189 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.7x
Fair PE Ratio17.1x

Price-To-Earnings vs Fair Ratio: 189 is good value based on its Price-To-Earnings Ratio (14.7x) compared to the estimated Fair Price-To-Earnings Ratio (17.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 189 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$6.68
HK$11.89
+78.0%
35.4%HK$19.00HK$8.00n/a4
Nov ’25HK$6.53
HK$11.89
+82.1%
35.4%HK$19.00HK$8.00n/a4
Oct ’25HK$7.77
HK$11.90
+53.1%
35.4%HK$19.00HK$8.00n/a4
Sep ’25HK$5.67
HK$11.90
+109.8%
35.4%HK$19.00HK$8.00n/a4
Aug ’25HK$6.53
HK$12.55
+92.2%
29.8%HK$19.00HK$10.00n/a4
Jul ’25HK$8.49
HK$12.57
+48.1%
29.7%HK$19.00HK$10.00n/a4
Jun ’25HK$9.32
HK$12.57
+34.9%
29.7%HK$19.00HK$10.00n/a4
May ’25HK$6.93
HK$9.99
+44.2%
9.1%HK$11.10HK$8.87n/a3
Apr ’25HK$7.34
HK$9.99
+36.1%
9.1%HK$11.10HK$8.87n/a3
Mar ’25HK$7.12
HK$8.54
+19.9%
4.5%HK$8.87HK$8.00n/a3
Feb ’25HK$5.26
HK$8.37
+59.1%
4.4%HK$8.74HK$8.00n/a2
Jan ’25HK$5.65
HK$8.33
+47.4%
3.9%HK$8.65HK$8.00n/a2
Dec ’24HK$5.89
HK$9.84
+67.1%
16.8%HK$12.01HK$8.00n/a3
Nov ’24HK$6.18
HK$9.84
+59.3%
16.8%HK$12.01HK$8.00HK$6.533
Oct ’24HK$5.89
HK$10.51
+78.4%
17.5%HK$12.50HK$8.00HK$7.774
Sep ’24HK$6.74
HK$10.01
+48.4%
19.2%HK$12.50HK$8.00HK$5.675
Aug ’24HK$7.77
HK$11.13
+43.2%
14.7%HK$12.50HK$8.00HK$6.535
Jul ’24HK$5.86
HK$11.24
+91.9%
15.3%HK$12.70HK$8.00HK$8.495
Jun ’24HK$6.90
HK$11.24
+62.9%
15.3%HK$12.70HK$8.00HK$9.325
May ’24HK$7.95
HK$11.05
+39.0%
17.0%HK$12.70HK$8.00HK$6.934
Apr ’24HK$8.10
HK$11.24
+38.8%
15.3%HK$12.70HK$8.00HK$7.345
Mar ’24HK$8.95
HK$11.73
+31.0%
9.1%HK$12.91HK$10.00HK$7.124
Feb ’24HK$9.61
HK$11.60
+20.7%
8.0%HK$12.37HK$10.00HK$5.264
Jan ’24HK$8.59
HK$11.78
+37.1%
7.7%HK$12.50HK$10.00HK$5.655
Dec ’23HK$8.60
HK$12.10
+40.7%
2.6%HK$12.50HK$11.60HK$5.895
Nov ’23HK$7.38
HK$12.25
+66.0%
4.3%HK$13.14HK$11.60HK$6.185

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies